Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: James Baker who wrote (3609)	6/20/1998 10:49:00 AM
From: doormouse	Read Replies (1) \| Respond to of 9523

[an embarrassment to] I think just backlash against. (Same thing happened to Jimi Hendrix when writers started snickering "his hair is falling out." Backlash.)

To: James Baker who wrote (3609)	6/20/1998 12:14:00 PM
From: Perry	Respond to of 9523

"these companies get virtually 100% approval because they would never waste their time and money with a drug that could not meet the FDA requirements. This is an embarrassment to the mighty PFE but NOT a disaster." James, thanks for the response. I thought it might be quite high and therefore the Zeldox news came as a big surprise. I guess the bigger question then is, is the virtual 100% approval rate on the 1st drug submission or would it include resubmissions. Thanks, Perry BTW I also think the Zeldox news is a surprise but not a disaster by any stretch of the imagination. I'm sure there's more good news in the future than bad so we can all relax. Near term who knows. Long PFE and short VVUS.